Publicaciones en las que colabora con Paula Aldaz Donamaria (18)

2023

  1. Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy

    Nature Metabolism, Vol. 5, Núm. 9, pp. 1544-1562

2022

  1. Author Correction: PR-LncRNA signature regulates glioma cell activity through expression of SOX factors (Scientific Reports, (2018), 8, 1, (12746), 10.1038/s41598-018-30836-5)

    Scientific Reports

  2. High SOX9 Maintains Glioma Stem Cell Activity through a Regulatory Loop Involving STAT3 and PML

    International Journal of Molecular Sciences, Vol. 23, Núm. 9

  3. SOX9 Triggers Different Epithelial to Mesenchymal Transition States to Promote Pancreatic Cancer Progression

    Cancers, Vol. 14, Núm. 4

2021

  1. Identification of a dexamethasone mediated radioprotection mechanism reveals new therapeutic vulnerabilities in glioblastoma

    Cancers, Vol. 13, Núm. 2, pp. 1-23

2020

  1. Methylation of MGMT promoter does not predict response to temozolomide in patients with glioblastoma in Donostia Hospital

    Scientific Reports, Vol. 10, Núm. 1

  2. SOX9 promotes tumor progression through the axis BMI1-p21CIP

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. SOX3 can promote the malignant behavior of glioblastoma cells

    Cellular Oncology, Vol. 42, Núm. 1, pp. 41-54

2018

  1. Indirect costs associated with glioblastoma: Experience at one hospital

    Neurologia, Vol. 33, Núm. 2, pp. 121-128

  2. PR-LncRNA signature regulates glioma cell activity through expression of SOX factors

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. High expression of MKP1/DUSP1 counteracts glioma stem cell activity and mediates HDAC inhibitor response

    Oncogenesis, Vol. 6, Núm. 12

  2. Oncogenic activity of SOX1 in glioblastoma

    Scientific Reports, Vol. 7

2016

  1. MTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance

    Expert Opinion on Therapeutic Targets, Vol. 20, Núm. 4, pp. 393-405

  2. SOX9 elevation acts with canonical WNT signaling to drive gastric cancer progression

    Cancer Research, Vol. 76, Núm. 22, pp. 6735-6746

  3. SOX9-regulated cell plasticity in colorectal metastasis is attenuated by rapamycin

    Scientific Reports, Vol. 6

  4. Stratification and therapeutic potential of PML in metastatic breast cancer

    Nature Communications, Vol. 7

  5. Targeting SOX2 as a therapeutic strategy in glioblastoma

    Frontiers in Oncology

2013

  1. Therapeutic strategies targeting Glioblastoma stem cells

    Recent Patents on Anti-Cancer Drug Discovery, Vol. 8, Núm. 3, pp. 216-227